Low nephron endowment increases susceptibility to salt-induced elevation of blood pressure in mice

View at publisher
Authors: Ileana Serrano Herrera, Rushelle L. Byfield, David A Bateman, Ling Li, Holly A. Hurst, Jacob Silberman, Qais Al-Awqati, Vivette D. D’Agati, Fangming Lin, Pamela I Good
Cited by: 1
References: 68

Abstract

OBJECTIVES: Humans born preterm have low nephron endowment and an increased risk for hypertension and chronic kidney disease (CKD) later in life. The risks of these sequelae are augmented by a higher incidence of postnatal kidney injury from ischemic, hypoxic and/or nephrotoxic insults. METHODS: To test the hypothesis that congenital nephron deficits in the absence of other renal insults are a risk factor for hypertension, and that salt intake modifies this response, we performed continuous ambulatory blood pressure (BP) monitoring before and after high salt diet in a novel mouse model of low nephron endowment (named Ret UB del ). RESULTS: We discovered that adult Ret UB del mice and controls have similar systolic and diastolic BP. After high salt diet, Ret UB del males and females had a greater rise in systolic BP, and Ret UB del females had a greater rise in diastolic BP than controls. In contrast, Ret UB del males had less of a rise in diastolic BP, revealing possible sex dimorphisms in mice with low nephron endowment. In females, salt loading was accompanied by less suppression of juxtaglomerular renin and a blunted rise in fractional excretion of urinary sodium, although sample stratification reduced the power to detect significant male-female differences. Ret UB del males had more of a CKD phenotype, suggesting that CKD did not contribute to salt-sensitivity. CONCLUSIONS: This study shows the impact of a modifiable dietary factor on the development of hypertension in mice with low nephron endowment.

Fields of Study & Subjects

Sodium Intake and Health Renin-Angiotensin System Studies Ion Transport and Channel Regulation

Publication details

Journal / source
Journal of Hypertension
Publisher
Ovid Technologies (Wolters Kluwer Health)
Volume
44
Issue
4
Pages
645–653
Publication date
22 January 2026
Language
EN